One of the largest pharmaceutical enterprises in the Kostroma region, the Ortat pharmaceutical Plant (part of the R-Pharm group) is implementing a new investment project. This is reported by SMI 44.
The company plans to increase its production capacity by purchasing new equipment. The total amount of investments will exceed 237 million rubles.
The investment project is intended for two years. Thanks to its implementation, the company will be able to accelerate the production of medicines, expand the range and improve the quality of the drugs, as well as create new jobs. The company will be entitled to an investment tax deduction.
As it became known earlier, R-Pharm group has registered a drug for the treatment of community-acquired pneumonia.
